The results of the above studies indicate that elevated expression of OPN induces a cascade of events leading to several changes in the tumor metastasis mechanism. This implies that by monitoring OPN levels, clinicians can better assess the prognosis of OS patients and tailor treatment strategies accordingly, ultimately improving patient care and outcomes. This evidence concerns the gene SPP1 and neoplasm.